Diagnostic histochemistry and clinical-pathological testings as molecular pathways to pathogenesis and treatment of the ageing neuromuscular system: a personal view

Biochim Biophys Acta. 2015 Apr;1852(4):563-84. doi: 10.1016/j.bbadis.2014.11.015. Epub 2014 Nov 24.

Abstract

Ageing of the neuromuscular system in elderhood ingravescently contributes to slowness, weakness, falling and death, often accompanied by numbness and pain. This article is to put in perspective examples from a half-century of personal and team neuromuscular histochemical-pathological and clinical-pathological research, including a number of lucky and instructive accomplishments identifying new treatments and new diseases. A major focus currently is on some important, still enigmatic, aspects of the ageing neuromuscular system. It is also includes some of the newest references of others on various closely-related aspects of this ageing system. The article may help guide others in their molecular-based endeavors to identify paths leading to discovering new treatments and new pathogenic aspects. These are certainly needed - our ageing and unsteady constituents are steadily increasing. This article is part of a Special Issue entitled: Neuromuscular Diseases: Pathology and Molecular Pathogenesis.

Keywords: Ageing muscle atrophy; Amyotrophic Lateral Sclerosis; Human muscle histochemistry; IVIG treatment; Multicramps; Treatable diabetic neuropathy.

Publication types

  • Review

MeSH terms

  • Aging* / genetics
  • Aging* / metabolism
  • Aging* / pathology
  • Humans
  • Neuromuscular Diseases* / diagnosis
  • Neuromuscular Diseases* / genetics
  • Neuromuscular Diseases* / metabolism
  • Neuromuscular Diseases* / pathology
  • Neuromuscular Diseases* / therapy